Park Avenue Securities’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,165
Closed -$219K 1463
2024
Q3
$219K Buy
5,165
+639
+14% +$33.5K ﹤0.01% 1311
2024
Q2
$232K Buy
4,526
+865
+24% +$49K ﹤0.01% 1263
2024
Q1
$229K Sell
3,661
-82
-2% -$5.58K ﹤0.01% 1272
2023
Q4
$280K Sell
3,743
-567
-13% -$40.6K ﹤0.01% 1148
2023
Q3
$367K Buy
+4,310
New +$409K 0.01% 961
2023
Q1
Sell
-4,821
Closed -$496K 717
2022
Q4
$496K Sell
4,821
-9
-0.2% -$1.04K 0.01% 780
2022
Q3
$512K Buy
4,830
+190
+4% +$20.8K 0.01% 708
2022
Q2
$509K Buy
4,640
+997
+27% +$98.7K 0.01% 714
2022
Q1
$380K Buy
3,643
+485
+15% +$50.4K 0.01% 859
2021
Q4
$386K Buy
3,158
+1,313
+71% +$146K 0.01% 819
2021
Q3
$212K Buy
+1,845
New +$196K ﹤0.01% 984

Other funds holding AMN

Park Avenue Securities's AMN Position: Q4 2024 in Review

Park Avenue Securities sold out of AMN Healthcare (AMN) in Q4 2024, closing a stake of 5,165 shares — an estimated $219K sold.

Park Avenue Securities first reported a position in AMN in Q3 2021 and held it in 11 quarters. The position peaked at $512K in Q3 2022. 278 funds tracked by Wall St. Rank hold AMN as of Q4 2024.

  • Park Avenue Securities reported no remaining AMN Healthcare position as of Q4 2024 after selling out during the quarter.
  • Park Avenue Securities sold 5,165 AMN Healthcare shares in Q4 2024, an estimated $219K.
  • Park Avenue Securities first reported a position in AMN Healthcare in Q3 2021 and held it in 11 quarters.
  • Park Avenue Securities's AMN Healthcare position peaked at $512K in Q3 2022.
  • 278 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2024.

Based on Park Avenue Securities's 13F filing for Q4 2024, filed 14 Jan 2025.